2003
DOI: 10.1053/plac.2002.0966
|View full text |Cite
|
Sign up to set email alerts
|

Human Placental Trophoblast Cells Express α-Tocopherol Transfer Protein

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
33
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 64 publications
(34 citation statements)
references
References 25 publications
1
33
0
Order By: Relevance
“…In humans, α -TTP has been demonstrated as being presented in term placenta as well as in early-pregnancy trophoblast [14,24] . Both cyto-and syncytiotrophoblasts are reported to express α -TTP [14,20] .…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In humans, α -TTP has been demonstrated as being presented in term placenta as well as in early-pregnancy trophoblast [14,24] . Both cyto-and syncytiotrophoblasts are reported to express α -TTP [14,20] .…”
Section: Discussionmentioning
confidence: 99%
“…The α -TTP-specifi c rat monoclonal antihuman antibody used in the current study was prepared by Prof. D. Rotzoll (University of Leipzig, Germany) [14] . Specifi city of the antibody used in this study was determined by staining liver tissue known as positive control for α -TTP and by exchanging the primary antibody with an isotype control antibody [rat immunoglobulin G (IgG)] (Figure 1 A).…”
Section: Antibody Preparationmentioning
confidence: 99%
See 1 more Smart Citation
“…In contrast, in wild-type fetuses, low-dose VE consistently failed to increase a-tocopherol levels in any tissue, which accounts for the absence of any reduction in oxidative DNA damage in þ/þ p53 fetuses. The mechanisms underlying this differential VE disposition in wild-type fetuses are not clear; but, as for the tissue-selective differences, these may include variations in membrane transporters 37,38 and, at least in the liver, metabolism of a-tocopherol by the cytochromes P450 CYP3A4 and CYP4F2, 39,40 which may be expressed the fetus towards the end of gestation. 41,42 The tissue-and p53 genotype-dependent nature of the antioxidative efficacy of low-dose VE may explain, in part, the conflicting published reports of antitumor efficacy of VE for different cancers.…”
Section: In Utero Origins Of Cancer/chen Et Almentioning
confidence: 99%
“…Further homeostatic control is provided by the fact that TTP's stability in cells is modulated by ubiquitination which, in turn, is regulated by ␣-tocopherol (61). Finally, TTP is also expressed in the brain (25,62) and the placenta (28,39,63). It is likely that in these locations, TTP provides an additional layer of regulation that maintains local ␣-tocopherol sufficiency in the most sensitive tissues, i.e.…”
Section: Discussionmentioning
confidence: 99%